CMPX vs LLY · $367.4M cap vs P/E 39, rev $65.18B
Compass Therapeutics Inc. (CMPX) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
CMPX does not have a complete income-statement cache yet.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
CMPX currently screens at market cap $367.4M. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the CMPX and LLY stock pages for the full models.
Not investment advice.